Figure 6: New prosthesis for leg amputees, obtained from
Lord’s website.
Other medical systems based on similar active
control elements are used in training devices for
rehabilitation purposes which allow an adjustable
resistance to the movement according to the
evolution of the patient (Dong, 2005).
4.3 Cancer Therapy
The biocompatibility and tolerability by humans and
animals to magnetorheological materials have been
tested successfully (Sheng, Flores and Liu, 1999).
Some techniques developed for cancer therapies
target chemotherapeutic agents to the tumor sites
employing magnetic nanoparticles as carriers is a
promising cancer treatment reducing side effects of
conventional chemotherapy.
Electron microscope investigations show that the
ferrofluids can be enriched in tumour tissue and
tumour cells (Alexiou, 2006). Therefore, these
studies show a remarkable improvement to the
conventional cancer therapy but still causes toxicity
to the body.
Other interesting studies are based in MR-fluids
introduced into the blood vessels supplying the
tumor. When a magnetic field is applied a seal is
formed, which blocks the blood flow and cut the
alimentation in oxygen, leading to tumor necrosis.
There are interesting in-vitro investigations on these
therapies (Sheng, Flores and Liu, 1999) concerning
the study of the seal kinetics and pressure
resistibility of the formed seal.
5 CONCLUSIONS
In this paper the characterisation of two new
magnethoreological fluids in a damper is presented.
The force response when the magnetic field varies is
studied both in static and dynamic conditions. The
remaining magnetisation when the external field
stops is analysed.
Different possible applications for the two fluids
developed are indicated for medical or non medical
purposes. In the future, the new possibilities of the
magnetorheological fluids are incalculable.
REFERENCES
Alexiou C. et al.; “Targeting cancer cells: magnetic
nanoparticles as drug carriers”, Eur. Biophys J, 2006.
Bar-Cohen, J., Mavroidis, C. et al..- “Virtual reality
robotic telesurgery simulations using MEMICA haptic
system”. Proceedings of SPIE’s 8th Annual
International Symposium on Smart Structures and
Materials, 2001.
Dong, S. “Rehabilitation device with variable resistance
and intelligent control”. Medical Engineering and
Physics, 2005.
Flores, G., Sheng, R. et al..-“Medical applications of
magnetorheological fluids: A possible new cancer
therapy”. 7th International Conference on
Electrorheological (ER) Fluids and
Magnetorheological (MR) Suspensions, 1999.
Neelakantan, V. et al.., “Force feedback system using
magnetorheological fluids for telerobotic surgery”.
International Congress on Industrial and commercial
applications of smart structures technologies, 2002.
Rabinow J., “The magnetic fluid Clutch”, AIEE Trans 67,
1948.
Rizzo, R., “Electromagnetic Modeling and Design of
Haptic Interface Prototypes Based on
Magnetorheological Fluids”. IEEE Transactions on
Magnetics, 2007.
Scilingo E.P., Sgambelluri N., De Rossi D., Bicchi A.,
“Haptic displays based on MR- fluids: design,
realization and psychophysical validation”,
Proceedings of the11th Symposium on Haptic
Interfaces for Virtual Environment and Teleoperator
Systems, 2003
Sheng, Flores and Liu, “In vitro investigation of a novel
cancer therapeutic method using embolizing properties
of magnetorheological fluids”, Journal of Magnetism
and Magnetic Materials 194, 1999.
Torcuato M., “Estudio de suspensiones
magnetorreológicas en medios no acuosos”. Master
Thesis, 2006.
Website: Lord, 2008. Web-site: www.lord.com.
BIODEVICES 2009 - International Conference on Biomedical Electronics and Devices
440